Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
AR positive
i
Other names:
AR, AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1, Androgen receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
367
Related biomarkers:
Expression
Mutation
CNA
Others
‹
›
Associations
(26)
News
Trials
Search handles
@DrChoueiri
@DrHBurstein
@Dr_R_Kurzrock
@EllisLab_
@pradeepbab
@teamoncology
Search handles
@DrChoueiri
@DrHBurstein
@Dr_R_Kurzrock
@EllisLab_
@pradeepbab
@teamoncology
Filter by
Latest
10ms
Discover the complexities of PSMA heterogeneity and regulation in metastatic #ProstateCancer with AR-positive and AR-negative phenotypes in this insightful discussion with @mishabeltran @DanaFarber and @AndreaMiyahira @PCFnews. #WatchNow on UroToday > https://t.co/pSgn6fDbJ3 (@urotoday)
10 months ago
Metastases
|
AR (Androgen receptor)
|
AR positive • AR negative
1year
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer @mishabeltran @NatureCancer #AACR2023 #AACR23 https://t.co/zbDct5XS4K (@imedverse)
1 year ago
Metastases
|
AR (Androgen receptor)
|
AR positive • AR negative
1year
💫ONLINE NOW @NatureCancer “Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer” by @mishabeltran @mkbakht & Co. @NatResCancer Read it here👇 https://t.co/xrn1NekyVD https://t.co/Nmu0c54fjm (@NatureCancer)
1 year ago
Metastases
|
AR (Androgen receptor)
|
AR positive • AR negative
1year
Couldn’t be prouder of the amazing work of @mkbakht dissecting the landscape of PSMA heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Congratulations @mishabeltran! @L_Porterlabrats https://t.co/OKBKsaO3Lh (@LisaPorter2)
1 year ago
Metastases
|
AR (Androgen receptor)
|
AR positive • AR negative
1year
Congrats @mishabeltran and team. Very nice work! Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer | Nature Cancer https://t.co/JilBPgP7zO (@AAytesLab)
1 year ago
Metastases
|
AR (Androgen receptor)
|
AR positive • AR negative
1year
So excited to share our new paper @NatureCancer on PSMA regulation in AR-positive and AR-negative prostate cancer. Congratulations to lead author @mkbakht @DanaFarber We are grateful for many wonderful collaborators @DanaFarber_GU @PCF_Science https://t.co/SwdSVhnAx3 (@mishabeltran)
1 year ago
AR (Androgen receptor)
|
AR positive • AR negative
1year
Outstanding work from @mishabeltran Lab and colleagues in @NatureCancer==> "Landscape of Prostate-Specific Membrane Antigen Heterogeneity and Regulation in AR-positive and AR-negative Metastatic Prostate Cancer" https://t.co/Fj31BHlFa7 @DanaFarber_GU @DanaFarber @OncoAlert https://t.co/zTQY5yyHjh (@DrChoueiri)
1 year ago
Metastases
|
AR (Androgen receptor)
|
AR positive • AR negative
1year
Important work from @mishabeltran @DanaFarber_GU Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer | Nature Cancer https://t.co/BRaBwa0KGF (@EllisLab_)
1 year ago
Metastases
|
AR (Androgen receptor)
|
AR positive • AR negative
1year
TNBC, MBC, progressed on all standard first line (AC, P-C)drugs. What is the best option in this case? Any role of CDK4/6i based on preliminary data along with PI3Ka targeting? This pt is AR positive, too (@pradeepbab)
1 year ago
Clinical
|
AR (Androgen receptor) • CDK4 (Cyclin-dependent kinase 4)
|
AR positive
over1year
RARE corner. What is it? Looks like ductal breast cancer under the microscope. Skin mets are unusual. May have PI3K pathway alterations as well as androgen receptor and Her2 positivity. These two men showed remarkable response to mTOR inhibitor based therapy (@Dr_R_Kurzrock)
over 1 year ago
HER-2 (Human epidermal growth factor receptor 2) • AR (Androgen receptor)
|
HER-2 positive • AR positive
over1year
We're thrilled to share results of a clinical trial led by @AlanHoMDPhD for people with androgen receptor-positive salivary #glandcancer. @AndrewChowMDPhD and @charlesrudin explore novel predictors of immunotherapy effectiveness against #lungcancer. ⬇️ https://t.co/YcV0Svntp2 (@MSK_DeptOfMed)
over 1 year ago
Clinical
|
AR (Androgen receptor)
|
AR positive
over1year
#SABCS2022 #bcsm so proud of my superstar mentee Hannah Krause sharing her work investigating mechanisms of ARSI resistance in AR positive TNBC @oreganruth @JoshLangMD @uw_hemeoncpc (@marina_sharifi)
over 1 year ago
AR (Androgen receptor)
|
AR positive
over1year
AR-positive subset of TNBC is definable. But to date, not clinically actionable. Perhaps as @shomgoel suggests, drugs active in luminal tumors (i.e. CDK4/6i) will have a role ?? (@DrHBurstein)
over 1 year ago
Clinical
|
AR (Androgen receptor) • CDK4 (Cyclin-dependent kinase 4)
|
AR positive
over2years
Enobosarm, an investigational, nonsteroidal, selective androgen receptor agonist, could represent a new treatment approach in estrogen receptor–positive, AR-positive metastatic breast cancer @breastoncdoc @UPMCHillmanCC #bcsm https://t.co/RLFz4alDLQ (@OncLive)
over 2 years ago
ER (Estrogen receptor) • AR (Androgen receptor)
|
AR positive
|
Ostarine (enobosarm)
over2years
Would you like hear Dr Hope Rugo @hoperugo @UCSF speak about novel treatments for TNBC like a new antibody drug conjugate, lovingly known as "sassy." Do you know what a SARM is? It is a special class of drugs for Androgen Receptor (AR) positive BC. Listen and find out. (@ourmbclife)
over 2 years ago
AR (Androgen receptor)
|
AR positive
over2years
I wonder similar concept applies to androgen receptor-positive breast cancer. (@teamoncology)
over 2 years ago
AR (Androgen receptor)
|
AR positive
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login